AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17391577 — intervention group
Group type: COMPARATOR
Intervention: Mailed copies of ED notes (control group).
Number of subjects: 2022
Study 12571662 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium-enriched pasta (1.7 g psyllium)
Number of subjects: 10
Study 12571662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta with 30 g sunflower oil and 3 g sodium propionate
Number of subjects: 10
Study 12571662 — intervention group
Group type: COMPARATOR
Intervention: Control pasta (without psyllium, fat, or sodium propionate)
Number of subjects: 10
Study 10696843 — intervention group
Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 0
Study 9172026 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia plus lumbar epidural anesthesia (Group CEGA)
Number of subjects: 37
Study 9172026 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (Group GA)
Number of subjects: 37
Study 8227791 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-ms impulse/high impedance electrode
Number of subjects: 32
Study 8227791 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-ms impulse/low impedance electrode
Number of subjects: 32
Study 8227791 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-ms impulse/high impedance electrode
Number of subjects: 32
Study 8227791 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-ms impulse/low impedance electrode
Number of subjects: 32
Study 3543072 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% fluorouracil under occlusion, mean application of 2 to 3 days per week
Number of subjects: 13
Study 3543072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 3543072 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% fluorouracil under occlusion
Number of subjects: 13
Study 30662380 — intervention group
Group type: EXPERIMENTAL
Intervention: Play-Informed, Caregiver-Implemented, Home-Based Intervention (PICIHBI)
Number of subjects: 24
Study 30662380 — intervention group
Group type: COMPARATOR
Intervention: Conventional one-on-one occupational therapy interventions
Number of subjects: 24
Study 27133814 — intervention group
Group type: EXPERIMENTAL
Intervention: SC plus true acupuncture
Number of subjects: 125
Study 27133814 — intervention group
Group type: EXPERIMENTAL
Intervention: SC plus non-penetrating acupuncture
Number of subjects: 125
Study 27133814 — intervention group
Group type: COMPARATOR
Intervention: SC
Number of subjects: 125
Study 27133814 — intervention group
Group type: EXPERIMENTAL
Intervention: SC, SC plus true acupuncture, SC plus non-penetrating acupuncture
Number of subjects: 125
Study 25511324 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative biomass stove with a chimney
Number of subjects: 0
Study 25511324 — intervention group
Group type: COMPARATOR
Intervention: Liquid propane gas stove
Number of subjects: 0
Study 22398158 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention to improve self-management of anxiety (n = 50)
Number of subjects: 94
Study 22398158 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (n = 44)
Number of subjects: 94
Study 20122815 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition supplemented with glutamine 0.18 g kg(‐1) d(‐1) for 20 d
Number of subjects: 36
Study 20122815 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral nutrition
Number of subjects: 36
Study 17768157 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 119
Study 17768157 — intervention group
Group type: COMPARATOR
Intervention: Indometacin (0.2 mg/kg)
Number of subjects: 119
Study 16429187 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (Fuji I)
Number of subjects: 32
Study 16429187 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin cement (Variolink II)
Number of subjects: 32
Study 12701260 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 5 mg of bupivacaine and 15 micrograms of fentanyl (Group F)
Number of subjects: 60
Study 12701260 — intervention group
Group type: COMPARATOR
Intervention: Subarachnoid anesthesia with 7.5 mg bupivacaine (Group B)
Number of subjects: 60
Study 10586384 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week program designed to improve coping
Number of subjects: 118
Study 10586384 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hr coping 'refresher' sessions at 5, 11, and 17 months
Number of subjects: 118
Study 10586384 — intervention group
Group type: COMPARATOR
Intervention: No refresher sessions following the 6-week course
Number of subjects: 118
Study 8914088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual apomorphine (10 mg)
Number of subjects: 13
Study 8914088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual apomorphine with Vitamin C (250 mg)
Number of subjects: 13
Study 8914088 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous apomorphine
Number of subjects: 13
Study 1860146 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg given at 2-week intervals for 6 doses
Number of subjects: 28
Study 1860146 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 28
Study 6614959 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial reserpine
Number of subjects: 24
Study 6614959 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 24
Study 29365157 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive inference of smoking status from user generated content (UGC)
Number of subjects: 826
Study 30413518 — intervention group
Group type: EXPERIMENTAL
Intervention: Plagiarism policies in journals
Number of subjects: 495
Study 30413518 — intervention group
Group type: EXPERIMENTAL
Intervention: Text matching software
Number of subjects: 495
Study 30413518 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of plagiarism measured by Turnitin
Number of subjects: 495
Study 30413518 — intervention group
Group type: EXPERIMENTAL
Intervention: Plagiarism severity
Number of subjects: 495
Study 30413518 — intervention group
Group type: EXPERIMENTAL
Intervention: Plagiarism occurrence by section
Number of subjects: 495
Study 26450146 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (H) 10 mg p.o. + placebo i.v.
Number of subjects: 10
Study 26450146 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone (FC) 0.1 mg p.o. + placebo i.v.
Number of subjects: 10
Study 26450146 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone (FC) 0.1 mg p.o. and Hydrocortisone (H) 10 mg p.o. + placebo i.v.
Number of subjects: 10
Study 26450146 — intervention group
Group type: COMPARATOR
Intervention: Placebo p.o. + placebo i.v.
Number of subjects: 10
Study 24200231 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 20
Study 24200231 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 20
Study 22360384 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal therapy (IPT)
Number of subjects: 53
Study 22360384 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy (ST)
Number of subjects: 53
Study 20093075 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory BCI using a three-stimulus paradigm with varying target stimuli (loudness, pitch, direction)
Number of subjects: 20
Study 18271229 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-letting puncture at 12 Jing-well points of the hand combined with fuming and washing with herbal lotion
Number of subjects: 80
Study 18271229 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of diuretic
Number of subjects: 80
Study 15613431 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 60
Study 15613431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12480038 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone SR 325 mg twice daily
Number of subjects: 594
Study 12480038 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone SR 425 mg twice daily
Number of subjects: 594
Study 12480038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 594
Study 10074017 — intervention group
Group type: EXPERIMENTAL
Intervention: Programme to coordinate preventive care led by specialist liaison nurses
Number of subjects: 597
Study 10074017 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 597
Study 7585844 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (9.4 mg/d for 1 year)
Number of subjects: 32
Study 7585844 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (2 years treatment)
Number of subjects: 32
Study 2262587 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 5 mg per piece, chewed 2 pieces 2 times daily for 10 min
Number of subjects: 14
Study 2262587 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 4 mg per piece, chewed 2 pieces 2 times daily for 6 days
Number of subjects: 14
Study 2262587 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 3 mg per piece, chewed 2 pieces 2 times daily for 6 days
Number of subjects: 14
Study 2262587 — intervention group
Group type: COMPARATOR
Intervention: Hibitane Dental (HD) rinse
Number of subjects: 14
Study 2262587 — intervention group
Group type: COMPARATOR
Intervention: Gum base without CHX or sweetening agent
Number of subjects: 14
Study 477315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 1200
Study 477315 — intervention group
Group type: EXPERIMENTAL
Intervention: Norinyl
Number of subjects: 1200
Study 477315 — intervention group
Group type: COMPARATOR
Intervention: Both brands
Number of subjects: 1200
Study 31858394 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg) 5 min before induction, followed by infusion (2 mg/kg/h) until the end of surgery
Number of subjects: 58
Study 31858394 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo) and infusion of 0.9% saline solution during surgery
Number of subjects: 58
Study 30996008 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic radiotherapy (HFSRT) concurrent with temozolomide (TMZ) at a dosage of 75 mg/m2 per day for at least 20 days
Number of subjects: 54
Study 29072375 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling with 70% glycolic acid peel (group 2)
Number of subjects: 60
Study 29072375 — intervention group
Group type: COMPARATOR
Intervention: Microneedling alone (group 1)
Number of subjects: 60
Study 25988992 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal skin-to-skin contact (M-SSC)
Number of subjects: 28
Study 25988992 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal skin-to-skin contact (P-SSC)
Number of subjects: 28
Study 23884497 — intervention group
Group type: EXPERIMENTAL
Intervention: LiquiBand® Flow Control
Number of subjects: 0
Study 23884497 — intervention group
Group type: EXPERIMENTAL
Intervention: High Viscosity Dermabond™
Number of subjects: 0
Study 21658782 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of d,l-fenfluramine (FEN)
Number of subjects: 37
Study 21658782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 19171319 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase, quit >= 5 days
Number of subjects: 152
Study 19171319 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase, quit >= 5 days
Number of subjects: 152
Study 19171319 — intervention group
Group type: COMPARATOR
Intervention: Follicular phase, quit < 24 h
Number of subjects: 152
Study 19171319 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase, quit < 24 h
Number of subjects: 152
Study 16954358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-food meal estimation (study 1)
Number of subjects: 145
Study 16954358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-food meal estimation (study 2)
Number of subjects: 145
Study 14974636 — intervention group
Group type: COMPARATOR
Intervention: Conventional phototherapy (CPT)
Number of subjects: 23
Study 14974636 — intervention group
Group type: COMPARATOR
Intervention: Fibre-optic phototherapy (FPT)
Number of subjects: 23
Study 11818170 — intervention group
Group type: EXPERIMENTAL
Intervention: High emotion events
Number of subjects: 0
Study 11818170 — intervention group
Group type: EXPERIMENTAL
Intervention: Low emotion events
Number of subjects: 0
Study 9651889 — intervention group
Group type: EXPERIMENTAL
Intervention: Golden-Ankle prosthetic foot
Number of subjects: 5
Study 9651889 — intervention group
Group type: COMPARATOR
Intervention: SACH prosthetic foot
Number of subjects: 5
Study 9651889 — intervention group
Group type: COMPARATOR
Intervention: Seattle prosthetic foot
Number of subjects: 5
Study 7661637 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethropexy (Kelly, Raz, Marshall‐Marchetti‐Krantz, Burch or simplified Ramirez technique)
Number of subjects: 70
Study 7661637 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethropexy
Number of subjects: 70
Study 7661637 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified Ramirez technique
Number of subjects: 70
Study 7661637 — intervention group
Group type: EXPERIMENTAL
Intervention: Kelly technique
Number of subjects: 70
Study 2526239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo provera (Depo‐medroxy Progesterone Acetate 25 mg and Estradiol Cypionate 5 mg)
Number of subjects: 206
Study 2526239 — intervention group
Group type: COMPARATOR
Intervention: HRP-102 (Norethisterone enanthate 50 mg and Estradiol Valerate 5 mg)
Number of subjects: 206
Study 153730 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 52
Study 153730 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 52
Study 27469458 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor Office Collaborative Care (DOCC)
Number of subjects: 321
Study 27469458 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 321
Study 25824428 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-motorized curved treadmill (NMCT)
Number of subjects: 10
Study 25824428 — intervention group
Group type: COMPARATOR
Intervention: Standard motorized treadmill (SMT)
Number of subjects: 10
Study 23607542 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vestibular cleansing capability assessment (measuring rice remaining in the oral vestibule)
Number of subjects: 30
Study 23607542 — intervention group
Group type: EXPERIMENTAL
Intervention: Masticatory efficiency assessment (measuring glucose eluted from gummy jelly)
Number of subjects: 30
Study 20974068 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic theory-based problem-solving approach
Number of subjects: 0
Study 20974068 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 19153091 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily starting on the first day of gonadotrophin stimulation
Number of subjects: 122
Study 19153091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 19153091 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily
Number of subjects: 122
Study 17924016 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with autonomous respiration (Group A)
Number of subjects: 40
Study 17924016 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with control respiration (Group C)
Number of subjects: 40
Study 15756164 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐HR hold-relax PNF stretch
Number of subjects: 60
Study 15756164 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐HR hold-relax PNF stretch
Number of subjects: 60
Study 15756164 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐HR hold-relax PNF stretch
Number of subjects: 60
Study 11518851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 25
Study 11518851 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 25
Study 11518851 — intervention group
Group type: COMPARATOR
Intervention: Nebivolol and Atenolol
Number of subjects: 25
Study 9778268 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral steroids
Number of subjects: 0
Study 9778268 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta-1b (IFNbeta-1b) therapy
Number of subjects: 0
Study 29490097 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat breakfast (FB; 35% carbohydrate, 20% protein, 45% fat; n = 13)
Number of subjects: 29
Study 29490097 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate breakfast (CB; 60% carbohydrate, 20% protein, 20% fat; n = 16)
Number of subjects: 29
Study 28857982 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal mattress suturing technique
Number of subjects: 30
Study 28857982 — intervention group
Group type: COMPARATOR
Intervention: Simple interrupted suturing technique
Number of subjects: 30
Study 26228433 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine and cisplatin for 24 weeks
Number of subjects: 425
Study 26228433 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 425
Study 23755969 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine)
Number of subjects: 353
Study 23755969 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept plus methotrexate
Number of subjects: 353
Study 23755969 — intervention group
Group type: COMPARATOR
Intervention: Both groups (after switching therapies)
Number of subjects: 353
Study 19574405 — intervention group
Group type: EXPERIMENTAL
Intervention: computer‐tailored e‐mail
Number of subjects: 458
Study 19574405 — intervention group
Group type: COMPARATOR
Intervention: generic, non‐tailored e‐mail
Number of subjects: 458
Study 16828780 — intervention group
Group type: EXPERIMENTAL
Intervention: cerivastatin
Number of subjects: 289
Study 16828780 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 289
Study 16828780 — intervention group
Group type: EXPERIMENTAL
Intervention: cerivastatin+nifedipine
Number of subjects: 289
Study 16828780 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 289
Study 15013587 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy (RT) with concurrent carboplatin/vindesine followed by surgery (arm A)
Number of subjects: 126
Study 15013587 — intervention group
Group type: COMPARATOR
Intervention: Conventional RT followed by surgery (arm B)
Number of subjects: 126
Study 11602814 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 20 mg
Number of subjects: 48
Study 11602814 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg
Number of subjects: 48
Study 11602814 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 48
Study 11602814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 9840854 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg tramadol
Number of subjects: 10
Study 9840854 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg metoclopramide
Number of subjects: 10
Study 9840854 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg lidocaine
Number of subjects: 10
Study 9840854 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL normal saline
Number of subjects: 10
Study 8077826 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous injection of local anaesthetic beneath the cuff
Number of subjects: 40
Study 8077826 — intervention group
Group type: COMPARATOR
Intervention: Standard axillary block anaesthesia
Number of subjects: 40
Study 2683281 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) - intravenous infusion of 1.5 million International Units during one hour
Number of subjects: 17187
Study 2683281 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl salicylic acid (ASA) - 160 mg daily for 30 days
Number of subjects: 17187
Study 2683281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of SK and ASA
Number of subjects: 17187
Study 2683281 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment only
Number of subjects: 17187
Study 2683281 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 17187
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium phosphate (MSP) 1, 3, 5, 10, 20, 30 mg/kg
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (MSS) 1, 3, 5, 10, 20, 30 mg/kg
Number of subjects: 0
Study 335572 — intervention group
Group type: COMPARATOR
Intervention: Vehicle or sterile saline
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP and MSS (equal doses)
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP 30 mg/kg
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP 40 mg
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSS 80 mg
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP 80 mg
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP and MSS (equivalent doses)
Number of subjects: 0
Study 335572 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP and MSS
Number of subjects: 0
Study 30978155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent PEG-Asparaginase (3 doses at 6-week intervals)
Number of subjects: 625
Study 30978155 — intervention group
Group type: COMPARATOR
Intervention: Continuous PEG-Asparaginase (10 doses at 2-week intervals)
Number of subjects: 625
Study 30978155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent PEG-Asparaginase
Number of subjects: 625
Study 30978155 — intervention group
Group type: COMPARATOR
Intervention: Continuous PEG-Asparaginase
Number of subjects: 625
Study 28549923 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistently sufficient vitamin D group (25(OH)D >50 nmol/L at months 3 and 24)
Number of subjects: 413
Study 28549923 — intervention group
Group type: COMPARATOR
Intervention: Fluctuating vitamin D group (25(OH)D >50 nmol/L at either point)
Number of subjects: 413
Study 28549923 — intervention group
Group type: COMPARATOR
Intervention: Consistently insufficient vitamin D group (serum 25(OH)D ≤50 nmol/L at months 3 and 24)
Number of subjects: 413